mometasone
UkraineDrugs containing this active substance
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children aged 3 years and older, as well as for the treatment of nasal polyps in patients aged 18 years and older.
Form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: Farmea
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used for the treatment of nasal polyps (in adults), symptoms of acute rhinosinusitis, and as an adjunct therapy in the treatment of sinusitis with antibiotics.
Form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used as an adjunct therapy for acute sinusitis (in adults and children from 12 years of age), for the treatment of symptoms of acute rhinosinusitis, and for the treatment of nasal polyps in patients from 18 years of age.
Form: spray, nasal suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
Manufacturer: JSC "Farmak" (packaging from bulk form of manufacturer Apotex Inc., Canada)
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used for the treatment of symptoms of acute rhinosinusitis as an adjunct in sinusitis (for adults and children from 12 years of age) and for the treatment of nasal polyps in patients from 18 years of age.
Form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is used for the treatment of seasonal and perennial allergic rhinitis.
Form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg azelastine 140 mcg ATC: R01AD
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 2 years of age. It is also used for the treatment of nasal polyps (in adults from 18 years of age) and acute rhinosinusitis (in adults and children from 12 years of age).
Form: spray, nasal, metered
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: FARMEA
-
The drug is used to treat inflammation and itching in dermatoses, specifically atopic dermatitis and psoriasis (except for widespread plaque psoriasis) in adults and children from 2 years of age.
Form: ointment
Active substance Dosage mometasone 1 mg/g ATC: D07AC13
Manufacturer: Yelfa Plant LLC
-
The drug is used to treat seasonal or perennial allergic rhinitis in adults and children from 2 years of age. It is also used for the treatment of nasal polyps (in adults from 18 years of age), symptoms of acute rhinosinusitis, and as an adjunct therapy for sinusitis in adults and children from 12 years of age.
Form: spray, nasal, metered
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: FARMEA
-
The drug is used to treat inflammation and itching in dermatoses, such as atopic dermatitis and psoriasis (except for common plaque psoriasis), in adults and children from 2 years of age.
Form: ointment
Active substance Dosage mometasone 1 mg/g ATC: D07AC13
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat symptoms of seasonal allergic or perennial rhinitis in adults and children aged 3 years and older, as well as to treat nasal polyps in patients aged 18 years and older.
Form: spray, nasal, suspension
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, batch release, quality control)
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 2 years of age. It is also used for the treatment of symptoms of acute rhinosinusitis as an adjunct therapy for sinusitis in adults and children from 12 years of age, as well as for the treatment of nasal polyps in patients from 18 years of age.
Form: spray, nasal suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
Manufacturer: Farmea
-
The drug is used to treat seasonal or perennial allergic rhinitis (in adults and children from 2 years of age), nasal polyps (in adults from 18 years of age), as well as to treat the symptoms of acute rhinosinusitis.
Form: spray, nasal, metered
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: Organon Haarlem bv
-
The drug is used to treat seasonal or perennial allergic rhinitis (in adults and children from 2 years of age), symptoms of acute rhinosinusitis, as well as for the treatment of nasal polyps (in adults from 18 years of age). It may also be used as an adjunct to antibiotic treatment for acute episodes of sinusitis in adults and children from 12 years of age.
Form: spray, nasal, metered
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: Organon Haarlem bv
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age, for acute rhinosinusitis (in adults and children from 12 years of age), as well as for the treatment of nasal polyps in patients from 18 years of age.
Form: spray, nasal suspension
Active substance Dosage mometasone 50 mcg ATC: R01AD09
Manufacturer: Cipla Ltd.
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used for the treatment of nasal polyps (in adults from 18 years of age), symptoms of acute rhinosinusitis, and as an adjunct therapy for sinusitis in adults and children from 12 years of age.
Form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
Manufacturer: Glenmark Pharmaceuticals Ltd.